Erasca and Bristol Myers Squibb Sign Drug Collaboration Deal
Erasca signed a collaboration deal with Bristol Myers Squibb to evaluate a pancreatic cancer drug combination.
Erasca signed a collaboration deal with Bristol Myers Squibb to evaluate a pancreatic cancer drug combination.